Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"PADRES" (Prior Axitinib as a Determinant of Outcome of REnal Surgery)

NCT03438708 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT03438708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03438708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"PADRES" (Prior Axitinib as a Determinant of Outcome of REnal Surgery)
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 5, 2018
Completion date
March 4, 2026
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma